Data / Form D filings / Ophidion Inc.
Ophidion Inc.: Form D filings
Ophidion Inc., a pharmaceuticals company in Bethlehem, PA, filed 4 Form D notices with the SEC between 2019 and 2024. The latest, on October 1, 2024, reports $655,166 sold of a $1.2 million offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 116 Research Dr, Suite 223, Bethlehem, PA, 18015
- Phone
- (610) 308-9020
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1791779
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 1, 2024 | New notice | $1,200,000 | $655,166 | $544,834 | 8 | Sep 17, 2024 | sec.gov |
| Sep 7, 2023 | New notice | $1,606,754 | $1,606,754 | 8 | Aug 15, 2023 | sec.gov | |
| Jan 14, 2020 | Amendment | $1,700,000 | $1,700,000 | 12 | Oct 3, 2019 | sec.gov | |
| Oct 23, 2019 | New notice | $1,200,000 | $755,000 | $445,000 | 7 | Oct 3, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Lark | Director | |
| Yacoub Habib | Executive Officer, Director, Promoter | |
| Julie Miwa | Director, Promoter | |
| Scott Fishman | Director | |
| Claudine Bruck | Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
- PLEOPHARMA, INC. $5.5 million · Aug 10, 2026
- Duo Oncology Inc. $1.6 million · Aug 7, 2026
Every Form D from the week of Sep 30, 2024 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Ophidion Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.